Regencell Bioscience Holdings Limited (NASDAQ:RGC – Get Free Report)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $78.00, but opened at $60.01. Regencell Bioscience shares last traded at $62.20, with a volume of 929,193 shares trading hands.
Regencell Bioscience Stock Performance
Regencell Bioscience Company Profile
Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.
Featured Articles
- Five stocks we like better than Regencell Bioscience
- What is the Australian Securities Exchange (ASX)
- Dan Ives Just Unveiled His AI ETF—Does It Live Up to the Hype?
- 3 Stocks to Consider Buying in October
- Congress’s May Stock Trades: What They Know That You Don’t
- Dividend Payout Ratio Calculator
- McDonald’s Is Down, But Long-Term Investors Can Still Take a Bite
Receive News & Ratings for Regencell Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Regencell Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
